REMSleep patent approved
By HME News Staff
Updated 10:53 AM CDT, Thu September 5, 2024
CLEARWATER, Fla. - REMSleep Holdings has announced that another utility patent for its Nasal Ventilation System has been allowed by the U.S. Patent and Trademark Office. The company expects to receive the patent approximately eight weeks after it files the necessary paperwork. REMSleep is now waiting for the delivery of silicone raw materials, expected during the first week of October, to produce inventory for market launch. Immediately after the launch of the Deltawave, REMSleep intends to submit 510K application for its next generation “Longevity,” a process that is expected to take approximately five months to clearance. A third generation CPAP interface mask to follow Longevity is expected to be on the market at the end of 2025. In July, REMSleep announced it had been awarded 510(K) clearance from the U.S. Food and Drug Administration for its new Deltawave CPAP Pillows Interface.
Comments